Paul Gordon

5.6k total citations · 1 hit paper
70 papers, 2.8k citations indexed

About

Paul Gordon is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Gordon has authored 70 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 35 papers in Surgery and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Gordon's work include Cardiac Valve Diseases and Treatments (29 papers), Coronary Interventions and Diagnostics (28 papers) and Cardiac Imaging and Diagnostics (25 papers). Paul Gordon is often cited by papers focused on Cardiac Valve Diseases and Treatments (29 papers), Coronary Interventions and Diagnostics (28 papers) and Cardiac Imaging and Diagnostics (25 papers). Paul Gordon collaborates with scholars based in United States, Netherlands and Italy. Paul Gordon's co-authors include Donald E. Cutlip, Richard E. Kuntz, Martin B. Leon, Daniel J. Diver, Donald S. Baim, Jeffrey J. Popma, Kalon K.L. Ho, David O. Williams, David Lasorda and Stuart Pocock and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Paul Gordon

66 papers receiving 2.7k citations

Hit Papers

A Clinical Trial Comparing Three Antithrombotic-Drug Regi... 1998 2026 2007 2016 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
    1998 1.2k citations Martin B. Leon, Donald S. Baim et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Gordon United States 23 2.2k 1.7k 577 568 391 70 2.8k
Daniel Caños United States 23 1.7k 0.8× 1.3k 0.8× 634 1.1× 669 1.2× 310 0.8× 70 2.5k
Zhenyi Xue United States 35 3.0k 1.4× 2.4k 1.4× 883 1.5× 1.1k 2.0× 583 1.5× 164 4.0k
Gennaro Sardella Italy 29 2.8k 1.3× 2.5k 1.5× 679 1.2× 1.2k 2.2× 205 0.5× 112 3.7k
S. Chiu Wong United States 21 2.6k 1.2× 1.6k 1.0× 408 0.7× 654 1.2× 155 0.4× 56 3.2k
Kazushige Kadota Japan 27 2.0k 0.9× 1.8k 1.1× 563 1.0× 849 1.5× 110 0.3× 259 2.8k
Itsik Ben‐Dor United States 35 3.4k 1.5× 1.4k 0.9× 1.2k 2.1× 926 1.6× 1.4k 3.6× 295 4.1k
Giovanni Mariscalco Italy 29 2.0k 0.9× 1.2k 0.7× 940 1.6× 250 0.4× 335 0.9× 146 3.0k
Ke Xu United States 32 3.5k 1.6× 1.3k 0.8× 945 1.6× 662 1.2× 1.6k 4.1× 101 4.1k
David J. Moliterno United States 25 2.4k 1.1× 2.2k 1.3× 443 0.8× 527 0.9× 88 0.2× 59 3.1k
Artur Dziewierz Poland 25 2.1k 0.9× 1.2k 0.7× 391 0.7× 810 1.4× 357 0.9× 249 2.5k

Countries citing papers authored by Paul Gordon

Since Specialization
Citations

This map shows the geographic impact of Paul Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gordon more than expected).

Fields of papers citing papers by Paul Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gordon. The network helps show where Paul Gordon may publish in the future.

Co-authorship network of co-authors of Paul Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gordon. A scholar is included among the top collaborators of Paul Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gordon. Paul Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Has, Phinnara, Ernie Shippey, Paul Gordon, et al.. (2024). C-83 | Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement In the United States: A Nationwide Analysis from the Vizient Clinical Database. Journal of the Society for Cardiovascular Angiography & Interventions. 3(5). 101909–101909. 1 indexed citations
2.
3.
Elbadawi, Ayman, Bryan E‐Xin Tan, Yasser Sammour, et al.. (2022). Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database. Catheterization and Cardiovascular Interventions. 99(5). 1636–1644. 1 indexed citations
4.
Ehsan, Afshin, et al.. (2020). Plugging the Hole: Diagnosis and Management of Post–Myocardial Infarction Ventricular Septal Defect. CASE. 4(4). 283–287. 2 indexed citations
5.
Kolte, Dhaval, Herbert D. Aronow, Kevin F. Kennedy, et al.. (2019). Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States. Journal of Thoracic and Cardiovascular Surgery. 159(1). 102–111.e11. 8 indexed citations
6.
Kolte, Dhaval, Sahil Khera, Sreekanth Vemulapalli, et al.. (2018). Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 11(12). 1175–1185. 84 indexed citations
7.
Apostolidou, Eirini, Herbert D. Aronow, Dhaval Kolte, et al.. (2018). Association Between Red Blood Cell Transfusion and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement. The Annals of Thoracic Surgery. 107(6). 1791–1798. 3 indexed citations
8.
Kolte, Dhaval, Sahil Khera, Sreekanth Vemulapalli, et al.. (2018). OUTCOMES FOLLOWING URGENT/EMERGENT TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE STS/ACC TVT REGISTRY. Journal of the American College of Cardiology. 71(11). A1009–A1009. 15 indexed citations
9.
Applegate, Robert J., James Hermiller, Paul Gordon, et al.. (2012). Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention. 7(9). 1030–1042. 3 indexed citations
10.
Caputo, Ronald, Michael Pencina, David J. Cohen, et al.. (2012). Impact of Drug Eluting Stent Length on Outcomes of Percutaneous Coronary Intervention (from the EVENT Registry). The American Journal of Cardiology. 110(3). 350–355. 27 indexed citations
11.
Waksman, Ron, Rebecca Torguson, Kimberly Kaneshige, et al.. (2012). TCT-621 Drug-Eluting Stent Event Registry of Thrombosis (DESERT): The International Drug-Eluting Stent Thrombosis Registry, Angiographic Assessment. Journal of the American College of Cardiology. 60(17). B180–B181.
12.
Cox, David A., Krishnankutty Sudhir, James Hermiller, et al.. (2010). EVALUATION OF THIENOPYRIDINE COMPLIANCE AND STENT THROMBOSIS RATES AFTER EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING STENT IMPLANTATION: 3-YEAR RESULTS FROM THE SPIRIT III ANALYSIS. Journal of the American College of Cardiology. 55(10). A191.E1791–A191.E1791. 1 indexed citations
13.
Caixeta, Adriano, Alexandra J. Lansky, Patrick W. Serruys, et al.. (2010). Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions. 3(12). 1220–1228. 37 indexed citations
14.
Verjans, Johan, Mark W.M. Schellings, Dagfinn Løvhaug, et al.. (2010). Early molecular imaging of interstitial changes in patients after myocardial infarction: Comparison with delayed contrast-enhanced magnetic resonance imaging. Journal of Nuclear Cardiology. 17(6). 1065–1072. 33 indexed citations
15.
Kereiakes, Dean J., Krishnankutty Sudhir, James Hermiller, et al.. (2010). COMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS. Journal of the American College of Cardiology. 55(10). A140.E1317–A140.E1317. 1 indexed citations
16.
Leon, Martin B., Donald S. Baim, Jeffrey J. Popma, et al.. (1999). A Clinical Trial Comparing Three Antithrombotic-Drug Regimens After Coronary Artery Stenting. Survey of Anesthesiology. 43(4). 194–195. 37 indexed citations
17.
Leon, Martin B., Donald S. Baim, Jeffrey J. Popma, et al.. (1998). A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting. New England Journal of Medicine. 339(23). 1665–1671. 1238 indexed citations breakdown →
18.
Núñez, Boris D., Miao Lin, Joseph P. Carrozza, et al.. (1994). Cocaine-induced transmural myocardial infarction in a Yorkshire swine with normal coronary arteries: Evidence for microvascular and/or epicardial coronary artery spasm. Cardiovascular Pathology. 3(2). 93–97. 2 indexed citations
19.
Gordon, Paul, C. Michael Gibson, David J. Cohen, et al.. (1993). Mechanisms of restenosis and redilation within coronary stents—Quantitative angiographic assessment. Journal of the American College of Cardiology. 21(5). 1166–1174. 186 indexed citations
20.
Kuntz, Richard E., Anna N.A. Tosteson, Aaron D. Berman, et al.. (1991). Predictors of Event-Free Survival after Balloon Aortic Valvuloplasty. New England Journal of Medicine. 325(1). 17–23. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Caños Breakdown of academic impact, for papers by Zhenyi Xue Breakdown of academic impact, for papers by Gennaro Sardella Breakdown of academic impact, for papers by S. Chiu Wong Breakdown of academic impact, for papers by Kazushige Kadota Breakdown of academic impact, for papers by Itsik Ben‐Dor Breakdown of academic impact, for papers by Giovanni Mariscalco Breakdown of academic impact, for papers by Ke Xu Breakdown of academic impact, for papers by David J. Moliterno Breakdown of academic impact, for papers by Artur Dziewierz
Rankless by CCL
2026